ArticleTherapeutic advances in medical oncology2019

Intensive first-line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in

Gemma Bruera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.